Last reviewed · How we verify
Pyrantel Pamoate
At a glance
| Generic name | Pyrantel Pamoate |
|---|---|
| Sponsor | Swiss Tropical & Public Health Institute |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis (PHASE2)
- The Bangladesh Environmental Enteric Dysfunction Study (NA)
- Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in Gabon (PHASE4)
- Triple Combinations Against Hookworm Infections in Lao (PHASE4)
- The Efficacy of Five Anthelmintic Regimes Against Trichuris Trichiura Infections in Schoolchildren in Jimma, Ethiopia (PHASE4)
- Efficacy Albendazole and Levamisole Against STH on Unguja (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pyrantel Pamoate CI brief — competitive landscape report
- Pyrantel Pamoate updates RSS · CI watch RSS
- Swiss Tropical & Public Health Institute portfolio CI